CSIMarket
 
Panacea Life Sciences Holdings Inc   (EXDI)
 

Panacea Life Sciences Holdings Inc's Suppliers Performance

EXDI's Supply Chain




 
EXDI Costs vs Sales of Suppliers Growth Panacea Life Sciences Holdings Inc's cost of sales deteriorated by -13.63 % year on year, sequentially cost of sales grew by 159.18 % in Q1.

• More on EXDI Suppliers



Panacea Life Sciences Holdings Inc's cost of sales deteriorated by -13.63 % year on year, sequentially cost of sales grew by 159.18 % in Q1.

• More on EXDI Suppliers




Panacea Life Sciences Holdings Inc's Comment on Supply Chain


The company manufactures nutraceutical and cannabinoid, kratom, and mushroom products, specializing in bovine and vegan soft gel production. It distributes products throughout the United States via corporate-owned stores and distribution stores acquired through N7. The product portfolio includes over 40 CBD and CBG SKUs, along with white label licensing and contract manufacturing services. The company employs proprietary extraction technology and maintains secure storage and tracking systems for product delivery. It utilizes the ERPCannabis system, based on SAP architecture, to manage financials, human resources, payroll, procurement, production planning, and materials management. In 2018, the company entered into an agreement with Quintel-MC, Inc. to research and define its business and manufacturing processes. The company complies with environmental regulations without significant impact on capital expenditures.

Panacea Life Sciences Holdings Inc's Comment on Supply Chain


The company manufactures nutraceutical and cannabinoid, kratom, and mushroom products, specializing in bovine and vegan soft gel production. It distributes products throughout the United States via corporate-owned stores and distribution stores acquired through N7. The product portfolio includes over 40 CBD and CBG SKUs, along with white label licensing and contract manufacturing services. The company employs proprietary extraction technology and maintains secure storage and tracking systems for product delivery. It utilizes the ERPCannabis system, based on SAP architecture, to manage financials, human resources, payroll, procurement, production planning, and materials management. In 2018, the company entered into an agreement with Quintel-MC, Inc. to research and define its business and manufacturing processes. The company complies with environmental regulations without significant impact on capital expenditures.







EXDI's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Panacea Life Sciences Holdings Inc 1.34 2.76 -7.67 11
SUBTOTAL 0.00 0.00 0.00 -


Sources: Panacea Life Sciences Holdings Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Panacea Life Sciences Holdings Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.